| FORM 3 | UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 |
| |||||||||||||||
1. Name and Address of Reporting Person*
(Street)
| 2. Date of Event Requiring Statement (Month/Day/Year) 01/08/2021 | 3. Issuer Name and Ticker or Trading Symbol DENBURY INC [ DEN ] | |||||||||||||
| 4. Relationship of Reporting Person(s) to Issuer (Check all applicable)
| 5. If Amendment, Date of Original Filed (Month/Day/Year) | ||||||||||||||
6. Individual or Joint/Group Filing (Check Applicable Line)
| |||||||||||||||
| Table I - Non-Derivative Securities Beneficially Owned | |||
|---|---|---|---|
| 1. Title of Security (Instr. 4) | 2. Amount of Securities Beneficially Owned (Instr. 4) | 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 4. Nature of Indirect Beneficial Ownership (Instr. 5) |
| Common Stock | 29,063(1) | D | |
| Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) | |||||||
|---|---|---|---|---|---|---|---|
| 1. Title of Derivative Security (Instr. 4) | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) | 4. Conversion or Exercise Price of Derivative Security | 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 6. Nature of Indirect Beneficial Ownership (Instr. 5) | ||
| Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||
| Performance Stock Units | (2) | 12/04/2023 | Common Stock | 29,063(2) | (2) | D | |
| Series B Warrants (Right to Buy) | 09/18/2020 | 09/18/2023 | Common Stock | 103(3) | 35.41 | D | |
| Explanation of Responses: |
| 1. Represents restricted stock units ("RSUs") from the Issuer for services to the Issuer. Each RSU represents a contingent right to receive one share of common stock, par value $0.001 per share (the "Common Stock"), of the Issuer. These RSUs will vest ratably on December 4, 2021, 2022 and 2023 and, subject to certain exceptions, will be settled in shares of Common Stock within 30 days following the third anniversary of the grant date. |
| 2. Represents performance stock units ("PSUs") from the Issuer for services to the Issuer. Each PSU represents a contingent right to receive one share of Common Stock of the Issuer. The PSUs vest based on the volume-weighted average price of a share of Common Stock achieving certain pre-established amounts for 60 consecutive trading days immediately preceding any date on or prior to the end of the three-year performance period, and, subject to certain exceptions, will be settled in shares of Common Stock within 30 days following the end of the three-year performance period. |
| 3. Represents series B warrants (the "Series B Warrants") to purchase shares of Common Stock. The Series B Warrants are exercisable for one share of Common Stock from the date of issuance until 5:00 p.m., New York time, on the expiration date. |
| Remarks: |
| /s/ Robbie Hudson, attorney-in-fact for Ms. Jennings | 01/19/2021 | |
| ** Signature of Reporting Person | Date | |
| Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | ||
| * If the form is filed by more than one reporting person, see Instruction 5 (b)(v). | ||
| ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). | ||
| Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. | ||
| Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. | ||
